APP13002 - Infectious Eye Diseases Treatment

Model: APP13002

Exhibitor: FORMOSA PHARMACEUTICALS , INC

Booth No: M520

Characteristic

√ Novel ophthalmic application of a known antibiotic as a homogeneous aqueous suspension and intended for development under the 505(b)(2) regulatory pathway.
√ Utilizing a non-fluoroquinolone antibiotic, which shows dual antibiotic and anti-inflammatory activity and broad antibacterial spectrum against the major pathogens of bacterial conjunctivitis.
√ Potential in treating multiple kinds of anterior Ocular Infections and discorders: Conjunctivitis, Keratitis, Blepharitis, Meibomian Gland Dysfunction (MGD).
√ Expected to have a more convenient dosing regimen with stable and non-irritating formulation superior to existing therapies.

Menu

APP13002 - Infectious Eye Diseases Treatment

Characteristic

Other Products

Products you may be interested in

Highest Rated Products